Eylea® (English Alternative)

Eylea is a drug used to treat wet age-related macular degeneration. It is also used to treat swelling in the retina caused by a blockage in the blood vessels.

Composition:

Eylea 40 mg/mL solution for injection in a vial. 1 mL solution for injection contains 40 mg aflibercept*. One vial contains an extractable volume of at least 0.1 mL, equivalent to at least 4 mg aflibercept. This provides a usable amount to deliver a single dose of 0.05 mL containing 2 mg aflibercept.

Side effects:

• Increased redness in the eye.
• Eye pain.
• Cataract.
• Vitreous (gel-like substance) detachment.
• Vitreous floaters.
• Moving spots in the field of vision.
• Increased pressure in the eye.

Package:

1 x 2 mg/0.05 ml Vial, 1 x 18-gauge × 1½-inch, 1 x 5-micron Needle, 1 x 30 G ½ Needle, 1 x 1-ml Syringe